Vascular News and Research

RSS

Research on diverse health benefits of oats in protecting heart

Eleven top scientists from around the globe presented the latest findings on the powerful compounds found in oats in a scientific session titled, Physicochemical Properties and Biological Functionality of Oats, at the 247th Annual Conference of the American Chemical Society in Dallas, TX

17 Mar 2014

Researchers discover certain proteins in osteoclasts that may be used to destroy cardiovascular calcification

Cardiovascular calcification (deposits of minerals in heart valves and blood vessels) is a primary contributor to heart disease, the leading cause of death among both men and women in the United States according the Centers for Disease Control and Prevention (CDC).

17 Mar 2014

Stem cell therapy may benefit patients with debilitating heart failure

Researchers want to know whether patients with debilitating heart failure can benefit by having their own stem cells injected into their ailing heart muscle.

14 Mar 2014

Microvascular coronary dysfunction in women may be triggered by emotional stress, say researchers

Researchers at the Barbra Streisand Women's Heart Center at the Cedars-Sinai Heart Institute have found that emotional stressors - such as those provoking anger - may cause changes in the nervous system that controls heart rate and trigger a type of coronary artery dysfunction that occurs more frequently in women than men.

14 Mar 2014

Positive margins have limited impact on RCC outcome

Positive vascular wall margins are not associated with systemic recurrence or cancer-specific survival in patients with nonmetastatic renal cell carcinoma with tumour thrombus, US research shows.

13 Mar 2014

Researchers suggest potential treatment target for HCMV infection

Discovering where a common virus hides in the body has been a long-term quest for scientists. Up to 80 percent of adults harbor the human cytomegalovirus (HCMV), which can cause severe illness and death in people with weakened immune systems.

11 Mar 2014

ThromboGenics receives IWT grant to study potential new biotherapeutics for DME

ThromboGenics NV, an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines for the back of the eye, today announces that it has been awarded a €3 million grant from the Flemish agency for Innovation by Science and Technology.

10 Mar 2014

3D scaffolds bring hope for lung regeneration

In end-stage lung disease, transplantation is sometimes the only viable therapeutic option, but organ availability is limited and rejection presents an additional challenge.

10 Mar 2014

Treating long wait-times dictate long-term success of spinal cord stimulation therapy

Success rates soared to 75% for patients who waited less than 2 years for a spinal cord stimulator (SCS) implant, compared with 15% for patients whose implants happened 20 years after the onset of pain, according to a retrospective analysis.

7 Mar 2014

New bioinspired gel material could help repair damaged teeth and bone

A bit of pressure from a new shrinking, sponge-like gel is all it takes to turn transplanted unspecialized cells into cells that lay down minerals and begin to form teeth.

6 Mar 2014

Report highlights benefits of different access approach to treat uterine fibroids

Interventional radiologists have devised a new way to access a woman's fibroids-by flipping her wrist and treating via an arm not groin artery-to nonsurgically shrink noncancerous growths in the muscular wall of the uterus. Researchers found this to be less painful and traumatic for women, allowing them to immediately sit up and move after uterine fibroid embolization (UFE)-with no overnight stay, according to a March article in the Society of Interventional Radiology's flagship publication, the Journal of Vascular and Interventional Radiology.

6 Mar 2014

Low-amplitude electric fields help hard-to-heal chronic wounds

Naturally occurring electricity in our cells is key to how our bodies function, and that includes the healing of wounds.

5 Mar 2014

Nanomedicine – Past, Present and Future

News-Medical speaks to Frank Boehm about the fundamentals of nanomedicine and the nanotechnologies of the future.

4 Mar 2014

Medical student receives award for finding out drugs to treat peripheral vascular disease

Working at a Saint Louis University laboratory, second-year medical student Weston Gordon performed several studies investigating two novel drug therapies that may be useful in the treatment of peripheral vascular disease in patients with Type 2 diabetes.

4 Mar 2014

Research discovery advances efforts to replace damaged heart muscle

In a study that began in a pair of infant siblings with a rare heart defect, Johns Hopkins researchers say they have identified a key molecular switch that regulates heart cell division and normally turns the process off around the time of birth. Their research, they report, could advance efforts to turn the process back on and regenerate heart tissue damaged by heart attacks or disease.

4 Mar 2014

Outbursts of anger may trigger heart attacks and strokes, shows study

Outbursts of anger may trigger heart attacks, strokes and other cardiovascular problems in the two hours immediately afterwards, according to the first study to systematically evaluate previous research into the link between the extreme emotion and all cardiovascular outcomes.

4 Mar 2014

Drug that blocks LTA4 hydrolase enzyme plays key role in body's inflammatory response

There have been great expectations regarding the production of a drug to block the enzyme LTA4 hydrolase, which plays a key role in the body's inflammatory response.

4 Mar 2014

Doctors devise new way to treat atrial fibrillation

Doctors in the U.S. and Japan have devised a way to treat atrial fibrillation by adding a little alcohol to minimally invasive therapies that target a cluster of misbehaving nerves known to trigger arrhythmia. In the most recent Journal of the American College of Cardiology (online before print), the researchers say the new therapy may dull or stop the transmission of electrical impulses that cause atrial fibrillation.

4 Mar 2014

Bayer Yakuhin submits marketing authorization application in Japan for EYLEA Injection

Regeneron Pharmaceuticals, Inc. today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd., has submitted an application for marketing authorization for EYLEA (aflibercept) Injection for the treatment of patients with diabetic macular edema (DME) to the Japanese Ministry of Health, Labour and Welfare.

3 Mar 2014

Twin brains reveal similar progressions of neuropathological changes

Despite widespread use of a single term, Alzheimer's disease is actually a diverse collection of diseases, symptoms and pathological changes.

3 Mar 2014

Vascular News and Research

Research on diverse health benefits of oats in protecting heart

Researchers discover certain proteins in osteoclasts that may be used to destroy cardiovascular calcification

Stem cell therapy may benefit patients with debilitating heart failure

Microvascular coronary dysfunction in women may be triggered by emotional stress, say researchers

Positive margins have limited impact on RCC outcome

Researchers suggest potential treatment target for HCMV infection

ThromboGenics receives IWT grant to study potential new biotherapeutics for DME

3D scaffolds bring hope for lung regeneration

Treating long wait-times dictate long-term success of spinal cord stimulation therapy

New bioinspired gel material could help repair damaged teeth and bone

Report highlights benefits of different access approach to treat uterine fibroids

Low-amplitude electric fields help hard-to-heal chronic wounds

Nanomedicine – Past, Present and Future

Medical student receives award for finding out drugs to treat peripheral vascular disease

Research discovery advances efforts to replace damaged heart muscle

Outbursts of anger may trigger heart attacks and strokes, shows study

Drug that blocks LTA4 hydrolase enzyme plays key role in body's inflammatory response

Doctors devise new way to treat atrial fibrillation

Bayer Yakuhin submits marketing authorization application in Japan for EYLEA Injection

Twin brains reveal similar progressions of neuropathological changes

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News